On Stocktwits, sentiment for HealthEquity ended on an 'extremely bullish' note on Wednesday, accompanied by an 83% jump in message volume. The stock was in the green during Wednesday’s extended ...

Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their price objective for the stock from $120.00 to $115.00 in a research ...

The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. Over the past few days HealthEquity (NASDAQ: HQY) shares have been rather sickly.

HealthEquity HQY has faced a challenging start to 2025, with the stock plunging more than 13.1% year to date compared with the industry’s 1.5% and S&P 500 Index’s 9.2% decline, respectively.